phillyvoice.com

Shortage of alcohol dependency drug threatens many in recovery – at a time when booze sales are up

For a long time, she drank every day, starting at 5 p.m. Eventually, she began drinking at 3 p.m. "There were days near the end where I would decide, 'Today, I'm taking the day off,' and I would drink ...

BioCorRx, Inc. Announces Initiation of Clinical Study by Majority-Owned Subsidiary BioCorRx Pharmaceuticals, Inc. Evaluating Long-Acting Naltrexone Implant With or Without ...

Clinical Study Evaluating a Long-Acting Naltrexone Implant Under the FDA's 505(b)(2) Pathway ANAHEIM, CA - January 14, 2026 (NEWMEDIAWIRE) - BioCorRx Inc. (OTCID: BICX) (the "Company"), a developer ...
AOL

Why Naltrexone Is Considered the ‘Ozempic for Alcohol’ Use Disorder

Naltrexone can help people cut back on how much alcohol they drink but is best used alongside behavioral and psychosocial support programs. A pill that costs less than a dollar has been called the ...
Science Daily

Faster approach for starting extended-release naltrexone to treat opioid use disorder shown effective

Starting people with opioid use disorder on extended-release, injectable naltrexone (XR-naltrexone) within five to seven days of seeking treatment is more effective than the standard treatment method ...
Medscape

Current Progress in Pharmacologic Treatment Strategies for Alcohol Dependence

Expert Rev Clin Pharmacol. 2012;5(4):427-435. Naltrexone is relatively well tolerated, and the primary side effects are gastrointestinal discomfort. Higher doses (above 50 mg/day) have been suggested ...
Seeking Alpha

BioCorRx Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the ...

ANAHEIM, CA, Jan. 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (BICX) (the “Company”), a developer and provider of innovative treatment programs for substance use and related ...